Repro Med CFO Karen Fisher to resign June 30, 2022; Tom Adams named interim CFO

KORU Medical Systems, Inc.

CFO Karen Fisher resigns effective June 30, 2022; no disagreements with company.
Transition Agreement includes severance per existing employment agreement and $60,000 payment.
Tom Adams, VP of Financial Planning & Analysis since Nov 2021, will serve as interim CFO from July 1.
Adams has 20+ years med-tech/pharma finance experience, previously at Integra Life Sciences and Pfizer.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Tom Adams

Interim Chief Financial Officer

KRMD · KORU Medical Systems, Inc.

Effective: 2022-07-01
Filed: May 18, 2022, 7:59 PM ET

In the interim, the Company’s Vice President of Financial Planning and Analysis, Tom Adams, will serve as Interim Chief Financial Officer of the Company effective July 1, 2022.

Departed

Karen Fisher

Chief Financial Officer

KRMD · KORU Medical Systems, Inc.

Effective: 2022-06-30
Successor: Tom Adams
Filed: May 18, 2022, 7:59 PM ET

As reported under Item 1.01 above, Karen Fisher, the Company’s Chief Financial Officer, will resign her employment effective as of June 30, 2022 to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tom Adams was appointed as Interim Chief Financial Officer at KORU Medical Systems, Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

In the interim, the Company’s Vice President of Financial Planning and Analysis, Tom Adams, will serve as Interim Chief Financial Officer of the Company effective July 1, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Karen Fisher departed as Chief Financial Officer at KORU Medical Systems, Inc..

Action: resign
Role: Chief Financial Officer

Exact text from the filing

As reported under Item 1.01 above, Karen Fisher, the Company’s Chief Financial Officer, will resign her employment effective as of June 30, 2022 to pursue other opportunities.

View on SEC.gov

KORU Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001161697-22-000259

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.